…
HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. It offers health savings accounts (HAS); investment platform; online-only automated investment advisory services through Advisor, a Web-based tool. The company also provides flexible spending accounts (FSA) for health and dependent care; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. In addition, the company offers HSA and FSA members with access to certain healthcare products, programs, and services through its marketplace. It serves clients through a direct sales force; and brokers and advisors, a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is based in Draper, Utah.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
HealthEquity administers health savings accounts and other consumer-directed benefits, offering recordkeeping, trustee services and digital engagement to employers and individuals. Long-term growth could be supported by rising HSA adoption linked to high-deductible health plans, demographic trends, and cross-selling opportunities on its scalable, fee-based platform.
Principal risks are regulatory or tax-law changes to HSAs, intensified competition from banks and fintechs, and operational or cybersecurity failures that could reduce assets and fees.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2026-01-31 | 2025-01-31 | 2024-01-31 | 2023-01-31 | 2022-01-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-01-31 | 2025-01-31 | 2024-01-31 | 2023-01-31 | 2022-01-31 |
| Income before tax | 277.43M | 116.03M | 75.04M | -38.10M | -66.74M |
| Net income | 215.20M | 96.70M | 55.71M | -26.14M | -44.29M |
| Selling general administrative | 232.91M | 132.26M | 103.66M | 95.63M | 84.38M |
| Selling and marketing expenses | 95.24M | 90.74M | 79.27M | 68.85M | 58.60M |
| Gross profit | 913.12M | 692.58M | 529.87M | 490.09M | 423.71M |
| Reconciled depreciation | 154.66M | 162.45M | 153.08M | 161.20M | 137.19M |
| Ebit | 334.56M | 175.09M | 129.34M | 38.92M | 34.64M |
| Ebitda | 489.22M | 337.54M | 282.42M | 200.12M | 171.82M |
| Depreciation and amortization | 154.66M | 162.45M | 153.08M | 161.20M | 137.19M |
| Operating income | 322.46M | 230.07M | 128.13M | 38.92M | 34.64M |
| Other operating expenses | 990.97M | 969.71M | 871.45M | 824.10M | 715.99M |
| Interest expense | 57.13M | 60.63M | 55.45M | 48.42M | 36.57M |
| Tax provision | 62.23M | 19.33M | 19.33M | -11.95M | -22.45M |
| Interest income | 11.73M | 13.91M | 12.14M | 1.76M | 1.50M |
| Net interest income | -45.40M | -46.72M | -43.32M | -46.66M | -36.57M |
| Income tax expense | 62.23M | 19.33M | 19.33M | -11.95M | -22.45M |
| Total revenue | 1313.43M | 1199.77M | 999.59M | 861.75M | 756.56M |
| Total operating expenses | 590.66M | 462.51M | 401.74M | 452.44M | 383.14M |
| Cost of revenue | 400.31M | 507.19M | 469.71M | 371.66M | 332.85M |
| Total other income expense net | -45.02M | -114.03M | -53.09M | -77.02M | -101.38M |
| Net income from continuing ops | 215.20M | 96.70M | 55.71M | -26.14M | -44.29M |
| Net income applicable to common shares | - | - | - | -26.14M | -44.29M |
| Breakdown | 2026-01-31 | 2025-01-31 | 2024-01-31 | 2023-01-31 | 2022-01-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-01-31 | 2025-01-31 | 2024-01-31 | 2023-01-31 | 2022-01-31 |
| Total assets | 3432.04M | 3448.55M | 3236.50M | 3088.90M | 3107.10M |
| Intangible assets | 1097.17M | 1204.66M | 835.95M | 936.36M | 973.14M |
| Other current assets | 69.66M | 63.80M | 48.56M | 31.79M | 38.49M |
| Total liab | 1324.85M | 1333.64M | 1201.48M | 1193.26M | 1254.53M |
| Total stockholder equity | 2107.20M | 2114.91M | 2035.02M | 1895.64M | 1852.58M |
| Deferred long term liab | - | - | - | - | 4.40M |
| Other current liab | 134.78M | 131.96M | 95.65M | 89.50M | 104.72M |
| Common stock | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M |
| Capital stock | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M |
| Retained earnings | 195.91M | 209.27M | 205.63M | 149.92M | 176.06M |
| Other liab | - | - | - | 95.37M | 114.03M |
| Good will | 1648.14M | 1648.14M | 1648.14M | 1648.14M | 1645.84M |
| Other assets | - | - | 0.00M | 52.18M | 49.81M |
| Cash | 318.93M | 295.95M | 403.98M | 254.27M | 225.41M |
| Total current liabilities | 156.85M | 156.32M | 117.09M | 131.06M | 153.19M |
| Net debt | 682.55M | 812.57M | 529.16M | 740.22M | 782.82M |
| Short term debt | 9.91M | 10.00M | 9.40M | 27.66M | 20.92M |
| Short long term debt | - | - | - | 17.50M | 8.75M |
| Short long term debt total | 1001.48M | 1108.52M | 933.14M | 994.49M | 1008.23M |
| Other stockholder equity | 1916.99M | 1905.63M | 1829.38M | 1745.72M | 1676.51M |
| Property plant equipment | - | - | - | 69.32M | 86.98M |
| Total current assets | 512.28M | 477.75M | 557.44M | 382.89M | 351.34M |
| Net tangible assets | - | - | - | -688.86M | -766.40M |
| Net receivables | 123.70M | 118.01M | 104.89M | 96.83M | 87.43M |
| Long term debt | 957.38M | 1056.30M | 874.97M | 907.84M | 922.08M |
| Accounts payable | 12.16M | 14.36M | 12.04M | 13.90M | 27.54M |
| Accumulated other comprehensive income | -5.71M | - | 0.00M | - | - |
| Non currrent assets other | 131.67M | 71.57M | -768.08M | 52.18M | 49.81M |
| Non current assets total | 2919.76M | 2970.80M | 2679.06M | 2706.01M | 2755.76M |
| Capital lease obligations | 44.10M | 52.22M | 58.17M | 69.15M | 77.40M |
| Breakdown | 2026-01-31 | 2025-01-31 | 2024-01-31 | 2023-01-31 | 2022-01-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-01-31 | 2025-01-31 | 2024-01-31 | 2023-01-31 | 2022-01-31 |
| Investments | 1.64M | -505.45M | -46.07M | -119.13M | 2.37M |
| Change to liabilities | - | - | - | -26.67M | -2.18M |
| Total cashflows from investing activities | -47.14M | -505.45M | -46.07M | -119.13M | -639.25M |
| Net borrowings | -100.00M | 175.00M | -54.38M | -8.75M | -53.12M |
| Total cash from financing activities | -386.98M | 57.57M | -47.04M | -2.67M | 394.86M |
| Change to operating activities | - | - | - | 2.87M | 15.01M |
| Net income | 215.20M | 96.70M | 55.71M | -26.14M | -44.29M |
| Change in cash | 22.98M | -108.03M | 149.71M | 28.85M | -103.39M |
| Begin period cash flow | 295.95M | 403.98M | 254.27M | 225.41M | 328.80M |
| End period cash flow | 318.93M | 295.95M | 403.98M | 254.27M | 225.41M |
| Total cash from operating activities | 457.09M | 339.86M | 242.83M | 150.65M | 141.00M |
| Issuance of capital stock | - | - | 0.00M | 0.00M | 456.64M |
| Depreciation | 154.66M | 162.45M | 153.08M | 161.20M | 137.19M |
| Other cashflows from investing activities | -45.17M | -503.37M | -44.38M | - | - |
| Change to inventory | - | - | 0.00M | - | - |
| Change to account receivables | -5.69M | -13.11M | -8.06M | -9.57M | -11.20M |
| Sale purchase of stock | -299.25M | -121.49M | 0.00M | - | - |
| Other cashflows from financing activities | 0.87M | -1.62M | 0.86M | -0.60M | 941.35M |
| Change to netincome | - | - | - | 45.70M | 42.02M |
| Capital expenditures | 1.97M | 2.08M | 46.07M | 119.13M | 137.08M |
| Change in working capital | -26.62M | -6.53M | -33.13M | -33.37M | 1.62M |
| Stock based compensation | 73.06M | 96.42M | 77.15M | 62.61M | 52.75M |
| Other non cash items | 1.06M | 3.64M | 4.01M | 3.53M | 17.15M |
| Free cash flow | 455.12M | 337.77M | 196.75M | 31.52M | 3.91M |
Sector: Healthcare Industry: Health Information Services
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| HQY HealthEquity Inc |
0.41 0.40% |
103.46 | 34.72 | 20.96 | 5.86 | 3.99 | 6.36 | 16.69 |
| VEEV Veeva Systems Inc Class A |
-0.89 0.29% |
301.53 | 43.49 | 29.59 | 12.48 | 5.79 | 10.39 | 33.41 |
| PMCUF Pro Medicus Limited |
-5.95 4.18% |
136.55 | 64.90 | 90.91 | 49.11 | 38.05 | 65.12 | 83.47 |
| TEM Tempus AI, Inc. Class A Common Stock |
-4.29 5.65% |
71.60 | - | - | 8.68 | 25.39 | 8.33 | - |
| MTHRY M3 Inc |
- -% |
5.67 | 31.84 | 26.25 | 0.05 | 4.60 | 0.04 | 0.12 |
HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. It offers health savings accounts (HAS); investment platform; online-only automated investment advisory services through Advisor, a Web-based tool. The company also provides flexible spending accounts (FSA) for health and dependent care; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. In addition, the company offers HSA and FSA members with access to certain healthcare products, programs, and services through its marketplace. It serves clients through a direct sales force; and brokers and advisors, a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is based in Draper, Utah.
15 West Scenic Pointe Drive, Draper, UT, United States, 84020
801 727 1000
2814
| Name | Title | Year Born |
|---|---|---|
| Mr. Jon Kessler | Pres, CEO & Director | 1968 |
| Mr. Tyson Murdock | Exec. VP & CFO | 1971 |
| Mr. Darcy G. Mott | Special Advisor | 1953 |
| Mr. Larry L. Trittschuh | Exec. VP & Chief Security Officer | 1972 |
| Mr. Elimelech Rosner | Exec. VP & CTO | 1957 |
| Mr. Richard Putnam | VP of Investor Relations | NA |
| Mr. Delano Ladd | Exec. VP, Gen. Counsel & Sec. | 1981 |
| Mr. Steve Lindsay | Exec. VP of Sales & Relationship Management | NA |
| Mr. Brad Bennion | Sr. VP of Corp. Devel. | NA |
| Ms. Tia Padia | Sr. VP of Marketing | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.